Author: Widjaja, Ivy; Wang, Chunyan; van Haperen, Rien; Gutiérrez-Ãlvarez, Javier; van Dieren, Brenda; Okba, Nisreen M.A.; Raj, V. Stalin; Li, Wentao; Fernandez-Delgado, Raul; Grosveld, Frank; van Kuppeveld, Frank J. M.; Haagmans, Bart L.; Enjuanes, Luis; Drabek, Dubravka; Bosch, Berend-Jan
Title: Towards a solution to MERS: protective human monoclonal antibodies targeting different domains and functions of the MERS-coronavirus spike glycoprotein Cord-id: psfusppi Document date: 2019_4_2
ID: psfusppi
Snippet: The Middle-East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus that causes severe and often fatal respiratory disease in humans. Efforts to develop antibody-based therapies have focused on neutralizing antibodies that target the receptor binding domain of the viral spike protein thereby blocking receptor binding. Here, we developed a set of human monoclonal antibodies that target functionally distinct domains of the MERS-CoV spike protein. These antibodies belong to six distinct
Document: The Middle-East respiratory syndrome coronavirus (MERS-CoV) is a zoonotic virus that causes severe and often fatal respiratory disease in humans. Efforts to develop antibody-based therapies have focused on neutralizing antibodies that target the receptor binding domain of the viral spike protein thereby blocking receptor binding. Here, we developed a set of human monoclonal antibodies that target functionally distinct domains of the MERS-CoV spike protein. These antibodies belong to six distinct epitope groups and interfere with the three critical entry functions of the MERS-CoV spike protein: sialic acid binding, receptor binding and membrane fusion. Passive immunization with potently as well as with poorly neutralizing antibodies protected mice from lethal MERS-CoV challenge. Collectively, these antibodies offer new ways to gain humoral protection in humans against the emerging MERS-CoV by targeting different spike protein epitopes and functions.
Search related documents:
Co phrase search for related documents- absence presence and additional binding: 1
- absence presence and loading concentration: 1
- absence presence and logistic regression: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63
- absence presence and luciferase activity: 1, 2, 3, 4, 5
- absence presence and luciferase reporter: 1, 2, 3, 4, 5
- absence presence and luciferase reporter gene: 1, 2
- absence presence and lymph node: 1, 2, 3, 4, 5
- absence presence and lymph spleen: 1, 2
- absence presence and mab absence: 1
- absence presence and mabs presence: 1
Co phrase search for related documents, hyperlinks ordered by date